ABSTRACT
Objective COVID-19 has resulted in the death of almost 4 million people till date1. However, the mortality rate across countries seems to be vastly different irrespective of their respective socio-economic backgrounds. It is well known now that COVID-19 is an acute inflammatory infectious disease that gets complicated by type-I interferon response2,3. However, the precise reason for variations in COVID-19 related mortality rates is unknown. A detailed understanding behind the evolution of mortality rate around the globe is needed.
Methods In this article, we show that a biological science guided machine learning-based approach can predict the evolution of mortality rates across countries. We collected the publicly available data of all the countries in the world with regard to the mortality rate and the relevant biological and socio-economical causes. The data was analyzed using a novel FFT driven machine learning algorithm.
Results Our results demonstrate how COVID-19 related mortality rate is closely dependent on a multitude of socio-economic factors (population density, GDP per capita, global health index and population above 65 years of age), environmental (PM2.5 air pollution) and lifestyle aka food habits (meat consumption per capita, alcohol consumption per capita, dairy product consumption per capita and sugar consumption per capita). Interestingly, we found that individually these parameters show no visible trend that can be generalized with mortality.
Conclusions We anticipate that our work will initiate conversations between health officials, policymakers and world leaders towards providing preventative measures against COVID-19 and future coronavirus-based diseases and endemics/ pandemics by taking a holistic view.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The data used is openly available at: https://ourworldindata.org/coronavirus and at: https://www.ghsindex.org
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵** Abhishek Srivastava, Department of Computer Science & Engineering, IIT Indore, MP, India; asrivastava{at}iiti.ac.in
Data Availability
All data produced in the present study are available upon reasonable request to the authors
